长链非编码RNA在骨肉瘤中的研究进展

发布时间：2018-04-10 01:15

  本文选题：长链非编码RNA　切入点：骨肉瘤　出处：《华中科技大学学报(医学版)》2017年06期

【摘要】：正骨肉瘤(Osteosarcoma,OS)是青少年最常见的原发性恶性骨肿瘤,年发病率为(1~4)/100万,男女发病率之比为1.22∶1~([1])。骨肉瘤患者预后极差,目前我国骨肉瘤患者的5年生存率为37.5%~77.6%,而治疗后复发、肺部转移的患者,其平均生存时间更是不超过1年~([2-3])。因此,为提高骨肉瘤患者的诊治率及改善预后,进一步探究骨肉瘤发病分
[Abstract]:Osteosarcoma Osteosarcoma (Osteosarcoma) is the most common primary malignant bone tumor in adolescents. The annual incidence rate of Osteosarcoma Osteosarcoma (Osteosarcoma) is 1 / 1 million, and the ratio between male and female is 1. 22: 1.The prognosis of osteosarcoma patients is very poor. At present, the 5-year survival rate of osteosarcoma patients in China is 37.5% or 77.6%, and the average survival time of patients with recurrent and pulmonary metastasis after treatment is less than 1 year ([2-3]).Therefore, in order to improve the diagnosis and treatment rate of osteosarcoma and improve the prognosis of osteosarcoma, to further explore the incidence of osteosarcoma
【作者单位】： 华中科技大学同济医学院附属协和医院骨科;
【分类号】：R738.1
，

本文编号：1729004